These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28404097)

  • 21. How far is Mexico from Viral Hepatitis Global Health Sector Strategy 2030 targets.
    García-Sepúlveda CA; Laguna-Meraz S; Panduro A
    Ann Hepatol; 2020; 19(2):123-125. PubMed ID: 32138870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress towards elimination goals for viral hepatitis.
    Cox AL; El-Sayed MH; Kao JH; Lazarus JV; Lemoine M; Lok AS; Zoulim F
    Nat Rev Gastroenterol Hepatol; 2020 Sep; 17(9):533-542. PubMed ID: 32704164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.
    Bottero J; Brouard C; Roudot-Thoraval F; Deuffic-Burban S; Hofliger P; Abergel A; Volant J; Dhumeaux D; Yazdanpanah Y;
    Liver Int; 2016 Oct; 36(10):1442-9. PubMed ID: 27043826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunoprophylaxis of viral hepatitis].
    Biesiada G; Mach T
    Przegl Lek; 2003; 60(9):598-601. PubMed ID: 15065341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. State of viral hepatitis care in 16 countries of Central and Eastern European Region.
    Chkhartishvili N; Holban T; Simonović Babić J; Alexiev I; Matičič M; Kowalska J; Horban A;
    Cent Eur J Public Health; 2019 Sep; 27(3):212-216. PubMed ID: 31580556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis c and human rights: comparison of legal experience of Ukraine and Georgia.
    Senyuta IY
    Wiad Lek; 2018; 71(2 pt 2):383-388. PubMed ID: 29786590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatitis B and C. Risk of transmission from infected health care workers to patients].
    Gerlich WH
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Apr; 47(4):369-78. PubMed ID: 15205780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral hepatitis in Bucharest.
    Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
    Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey.
    Spina A; Eramova I; Lazarus JV
    BMC Infect Dis; 2014; 14 Suppl 6(Suppl 6):S15. PubMed ID: 25252705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B and C surveillance and screening programmes in the non-EU/EEA Member States of the WHO European Region: survey findings from 10 countries, 2012.
    Mozalevskis A; Eramova I; Safreed-Harmon K; Lazarus JV
    Euro Surveill; 2016 Jun; 21(22):. PubMed ID: 27277421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence and risk factors for hepatitis B and C virus infection in Damietta Governorate, Egypt.
    Edris A; Nour MO; Zedan OO; Mansour AE; Ghandour AA; Omran T
    East Mediterr Health J; 2014 Oct; 20(10):605-13. PubMed ID: 25356691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of hepatitis B and hepatitis C virus infection in human of Mymensingh, Bangladesh.
    Rudra S; Chakrabarty P; Poddar B
    Mymensingh Med J; 2011 Apr; 20(2):183-6. PubMed ID: 21522084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana.
    Mahoney FJ; Lawrence M; Scott C; Le Q; Lambert S; Farley TA
    Pediatrics; 1995 Dec; 96(6):1113-6. PubMed ID: 7491231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovative strategies for the elimination of viral hepatitis at a national level: A country case series.
    Schröeder SE; Pedrana A; Scott N; Wilson D; Kuschel C; Aufegger L; Atun R; Baptista-Leite R; Butsashvili M; El-Sayed M; Getahun A; Hamid S; Hammad R; 't Hoen E; Hutchinson SJ; Lazarus JV; Lesi O; Li W; Binti Mohamed R; Olafsson S; Peck R; Sohn AH; Sonderup M; Spearman CW; Swan T; Thursz M; Walker T; Hellard M; Howell J
    Liver Int; 2019 Oct; 39(10):1818-1836. PubMed ID: 31433902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
    U.S. Public Health Service
    MMWR Recomm Rep; 2001 Jun; 50(RR-11):1-52. PubMed ID: 11442229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population planning: a well co-ordinated approach required.
    Asian Pac Popul Programme News; 1984; 13(1):17-9. PubMed ID: 12313052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions.
    Duffell EF; Hedrich D; Mardh O; Mozalevskis A
    Euro Surveill; 2017 Mar; 22(9):. PubMed ID: 28277217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.
    Chu CJ; Lee SD
    J Gastroenterol Hepatol; 2008 Apr; 23(4):512-20. PubMed ID: 18397482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health care-associated transmission of hepatitis B & C viruses in dental care (dentistry).
    Younai FS
    Clin Liver Dis; 2010 Feb; 14(1):93-104; ix. PubMed ID: 20123443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to improve access to therapy in hepatitis B patients.
    Subic M; Zoulim F
    Liver Int; 2018 Feb; 38 Suppl 1():115-121. PubMed ID: 29427482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.